Raj Shah

Raj Shah

Director/Board Member at
TARIS BioMedical LLC
48 year
Health Technology
Finance
Consumer Services

Profile

Mr. Rajeev M.
Shah is a Managing Partner at RA Capital Management LP, a Managing Partner at RA Capital Management LP and a Member at Big Brothers Big Sisters of Massachusetts Bay.
He is on the Board of Directors at TARIS BioMedical LLC and Texas Radiological Society.
Mr. Shah is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools.
Mr. Shah was previously employed as an Independent Director by Black Diamond Therapeutics, Inc., an Independent Director by Eidos Therapeutics, Inc., an Independent Director by Solid Biosciences, Inc., an Independent Director by Satsuma Pharmaceuticals, Inc., an Independent Director by Kala Pharmaceuticals, Inc., an Independent Director by Ra Pharmaceuticals, Inc., an Independent Director by KalVista Pharmaceuticals, Inc., an Independent Director by Civitas Therapeutics, Inc., and a Senior Project Leader by Altus Pharmaceuticals, Inc. He also served on the board at KalVista Pharmaceuticals Ltd. He holds a BA from Cornell University, where he majored in Chemistry.

Raj Shah active positions

CompaniesPositionStart
Portfolio Manager-Equities 01/09/2004
Director/Board Member -
Private Equity Investor 01/06/2004
Corporate Officer/Principal -
Director/Board Member -

Former positions of Raj Shah

CompaniesPositionEnd
SOLID BIOSCIENCES INC. Director/Board Member 11/06/2024
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 17/01/2024
SATSUMA PHARMACEUTICALS, INC. Director/Board Member 08/06/2023
KALA BIO, INC. Director/Board Member 15/10/2021
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Raj Shah's experience

Training of Raj Shah

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance